{
  "trial_id": "NCT00497146",
  "trial_group": "chronic kidney disease",
  "generated-by-gpt4-omni-zs": {
    "gen-response": "Age, gender, estimated glomerular filtration rate (GFR), serum intact parathyroid hormone (iPTH) level, corrected serum calcium level, phosphorous level, serum albumin level, left ventricular ejection fraction, septal wall thickness, use of renin-angiotensin-aldosterone system (RAAS) inhibitors, baseline cardiac magnetic resonance imaging (MRI) results.",
    "evaluated-by-gpt4-omni": {
      "matched_features": [
        [
          "Age",
          "Age"
        ],
        [
          "Sex: Female",
          "gender"
        ],
        [
          "Baseline RAAS Status",
          "use of renin-angiotensin-aldosterone system (RAAS) inhibitors"
        ]
      ],
      "remaining_reference_features": [
        "Categorical",
        "Male",
        "Diabetic Status",
        "Age at Beginning of Long term Follow-up Period",
        "Gender at Beginning of Long term Follow-up Period"
      ],
      "remaining_candidate_features": [
        "estimated glomerular filtration rate (GFR)",
        "serum intact parathyroid hormone (iPTH) level",
        "corrected serum calcium level",
        "phosphorous level",
        "serum albumin level",
        "left ventricular ejection fraction",
        "septal wall thickness",
        "baseline cardiac magnetic resonance imaging (MRI) results."
      ]
    }
  },
  "generated-by-gpt4-omni-ts": {
    "gen-response": "Age, Continuous, Sex: Female, Male, Race/Ethnicity, Customized, Region of Enrollment, Estimated Glomerular Filtration Rate (eGFR), Serum Intact Parathyroid Hormone (iPTH), Corrected Serum Calcium Level, Phosphorous Level, Serum Albumin, Left Ventricular Ejection Fraction, Septal Wall Thickness, Use of RAAS Inhibitors, Baseline Cardiac MRI",
    "evaluated-by-gpt4-omni": {
      "matched_features": [
        [
          "Age",
          "Age"
        ],
        [
          "Sex: Female",
          "Sex: Female"
        ],
        [
          "Male",
          "Male"
        ],
        [
          "Baseline RAAS Status",
          "Use of RAAS Inhibitors"
        ]
      ],
      "remaining_reference_features": [
        "Categorical",
        "Diabetic Status",
        "Age at Beginning of Long term Follow-up Period",
        "Gender at Beginning of Long term Follow-up Period"
      ],
      "remaining_candidate_features": [
        "Race/Ethnicity",
        "Region of Enrollment",
        "Estimated Glomerular Filtration Rate (eGFR)",
        "Serum Intact Parathyroid Hormone (iPTH)",
        "Corrected Serum Calcium Level",
        "Phosphorous Level",
        "Serum Albumin",
        "Left Ventricular Ejection Fraction",
        "Septal Wall Thickness",
        "Baseline Cardiac MRI"
      ]
    }
  },
  "generated-by-llama3-70b-in-ts": {
    "gen-response": "Age, Continuous, Sex: Female, Male, Race/Ethnicity, Customized, Region of Enrollment, Estimated Glomerular Filtration Rate (eGFR), Serum Intact Parathyroid Hormone (iPTH), Corrected Serum Calcium, Phosphorous, Serum Albumin, Left Ventricular Ejection Fraction (LVEF), Septal Wall Thickness, Systolic Blood Pressure, Diastolic Blood Pressure.",
    "evaluated-by-gpt4-omni": {
      "matched_features": [
        [
          "Age",
          "Age"
        ],
        [
          "Sex: Female",
          "Sex: Female"
        ],
        [
          "Male",
          "Male"
        ],
        [
          "Baseline RAAS Status",
          "Baseline RAAS Status"
        ]
      ],
      "remaining_reference_features": [
        "Categorical",
        "Diabetic Status",
        "Age at Beginning of Long term Follow-up Period",
        "Gender at Beginning of Long term Follow-up Period"
      ],
      "remaining_candidate_features": [
        "Race/Ethnicity",
        "Region of Enrollment",
        "Estimated Glomerular Filtration Rate (eGFR)",
        "Serum Intact Parathyroid Hormone (iPTH)",
        "Corrected Serum Calcium",
        "Phosphorous",
        "Serum Albumin",
        "Left Ventricular Ejection Fraction (LVEF)",
        "Septal Wall Thickness",
        "Systolic Blood Pressure",
        "Diastolic Blood Pressure"
      ]
    }
  },
  "generated-by-llama3-70b-in-zs": {
    "gen-response": "Age, sex, race, ethnicity, body mass index (BMI), estimated glomerular filtration rate (GFR), serum intact parathyroid hormone (iPTH) value, corrected serum calcium level, phosphorous level, serum albumin, left ventricular (LV) ejection fraction, septal wall thickness, systolic blood pressure, diastolic blood pressure, history of diabetes, history of hypertension, history of cardiovascular disease, use of renin-angiotensin-aldosterone system (RAAS) inhibitors.",
    "evaluated-by-gpt4-omni": {
      "matched_features": [
        [
          "Age",
          "Age"
        ],
        [
          "Sex: Female",
          "sex"
        ],
        [
          "Baseline RAAS Status",
          "use of renin-angiotensin-aldosterone system (RAAS) inhibitors."
        ],
        [
          "Diabetic Status",
          "history of diabetes"
        ]
      ],
      "remaining_reference_features": [
        "Categorical",
        "Male",
        "Age at Beginning of Long term Follow-up Period",
        "Gender at Beginning of Long term Follow-up Period"
      ],
      "remaining_candidate_features": [
        "race",
        "ethnicity",
        "body mass index (BMI)",
        "estimated glomerular filtration rate (GFR)",
        "serum intact parathyroid hormone (iPTH) value",
        "corrected serum calcium level",
        "phosphorous level",
        "serum albumin",
        "left ventricular (LV) ejection fraction",
        "septal wall thickness",
        "systolic blood pressure",
        "diastolic blood pressure",
        "history of hypertension",
        "history of cardiovascular disease"
      ]
    }
  }
}